Comparing two methods for monitoring brain oxygen in severe traumatic brain injury
Brain Oxygen Optimization in Severe TBI (BOOST3): a Comparative Effectiveness Study to Test the Efficacy of a Prescribed Treatment Protocol Based on Monitoring the Partial Pressure of Brain Tissue Oxygen.
This study is testing two different ways to monitor brain oxygen levels in patients with severe traumatic brain injury to see which method helps them get better and stay safer in the ICU.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 1094 (estimated) |
| Ages | 14 Years and up |
| Sex | All |
| Sponsor | University of Michigan Academic / other |
| Locations | 48 sites (Los Angeles, California and 47 other locations) |
| Trial ID | NCT03754114 on ClinicalTrials.gov |
What this trial studies
BOOST3 is a randomized clinical trial designed to evaluate the effectiveness of two different strategies for monitoring and treating patients with traumatic brain injury (TBI) in the intensive care unit. One strategy focuses on both intracranial pressure (ICP) and brain tissue oxygen (PbtO2) levels, while the other relies solely on ICP monitoring. The study aims to determine which approach is safer and more effective in managing TBI patients by adjusting treatments based on the monitored parameters. Both monitoring techniques are FDA-approved and commonly used in clinical practice, but their comparative effectiveness remains unclear.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals aged 14 and older with non-penetrating traumatic brain injuries and a Glasgow Coma Scale score between 3 and 8.
Not a fit: Patients with non-survivable injuries or those with contraindications to intracranial probe placement may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment protocols for patients with severe traumatic brain injuries, potentially enhancing recovery outcomes.
How similar studies have performed: While both monitoring strategies are commonly used, this study is novel in its direct comparison of their effectiveness in a randomized setting.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Non-penetrating traumatic brain injury * Glasgow Coma Scale (GCS) 3-8 measured off paralytics * Glasgow Coma Scale motor score \< 6 if endotracheally intubated * Evidence of intracranial trauma on CT scan * Able to place intracranial probes and randomize within 6 hours of arrival at enrolling hospital * Able to place intracranial probes and randomize within 12 hours from injury * Age greater than or equal to 14 years Exclusion Criteria: * Non-survivable injury * Bilaterally absent pupillary response in the absence of paralytic medication * Contraindication to the placement of intracranial probes * Treatment of brain tissue oxygen values prior to randomization * Planned use of devices which may unblind treating physicians to brain tissue hypoxia * Systemic sepsis at screening * Refractory hypotension * Refractory systemic hypoxia * PaO2/FiO2 ratio \< 150 * Known pre-existing neurologic disease with confounding residual neurological deficits * Known inability to perform activities of daily living (ADL) without assistance prior to injury * Known active drug or alcohol dependence that, in the opinion of site investigator, would interfere with physiological response to brain tissue oxygen treatments * Pregnancy * Prisoner * On EFIC Opt-Out list as indicated by a bracelet or medical alert
Where this trial is running
Los Angeles, California and 47 other locations
- Cedars-Sinai Medical Center — Los Angeles, California, United States (Recruiting)
- Ronald Reagan UCLA Medical Center — Los Angeles, California, United States (Active_not_recruiting)
- Stanford University Medical Center — Palo Alto, California, United States (Recruiting)
- UC Davis Medical Center — Sacramento, California, United States (Recruiting)
- San Francisco General Hospital — San Francisco, California, United States (Active_not_recruiting)
- University of Colorado Hospital — Aurora, Colorado, United States (Active_not_recruiting)
- Yale New Haven Hospital — New Haven, Connecticut, United States (Recruiting)
- MedStar Washington Hospital Center — Washington, DC, District of Columbia, United States (Withdrawn)
- UF Health Shands Hospital — Gainesville, Florida, United States (Recruiting)
- University of Chicago Medical Center — Chicago, Illinois, United States (Recruiting)
- Maine Medical Center — Portland, Maine, United States (Recruiting)
- University of Maryland Medical Center — Baltimore, Maryland, United States (Recruiting)
- Johns Hopkins Hospital — Baltimore, Maryland, United States (Recruiting)
- Massachusetts General Hospital — Boston, Massachusetts, United States (Recruiting)
- Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States (Active_not_recruiting)
- UMASS Memorial Medical Center — Worcester, Massachusetts, United States (Recruiting)
- University of Michigan — Ann Arbor, Michigan, United States (Recruiting)
- Detroit Receiving Hospital — Detroit, Michigan, United States (Recruiting)
- Henry Ford Hospital — Detroit, Michigan, United States (Recruiting)
- Regions Hospital — Saint Paul, Minnesota, United States (Recruiting)
- Cooper University Hospital — Camden, New Jersey, United States (Recruiting)
- University of New Mexico Hospital — Albuquerque, New Mexico, United States (Recruiting)
- Kings County Hospital Center — Brooklyn, New York, United States (Withdrawn)
- North Shore University Hospital — ManHASSET, New York, United States (Recruiting)
- NYP Columbia University Medical Center — New York, New York, United States (Recruiting)
- Strong Memorial Hospital — Rochester, New York, United States (Recruiting)
- SUNY Upstate Medical University — Syracuse, New York, United States (Recruiting)
- University of North Carolina Medical Center — Chapel Hill, North Carolina, United States (Recruiting)
- Duke University Hospital — Durham, North Carolina, United States (Recruiting)
- University of Cincinnati Medical Center — Cincinnati, Ohio, United States (Recruiting)
- OSU Wexner Medical Center — Columbus, Ohio, United States (Recruiting)
- Riverside Methodist Hospital — Columbus, Ohio, United States (Active_not_recruiting)
- Oregon Health & Science University Hospital — Portland, Oregon, United States (Recruiting)
- Penn Presbyterian Medical Center — Philadelphia, Pennsylvania, United States (Recruiting)
- Thomas Jefferson University Hospital — Philadelphia, Pennsylvania, United States (Recruiting)
- UPMC Presbyterian Hospital — Pittsburgh, Pennsylvania, United States (Recruiting)
- Parkland Hospital — Dallas, Texas, United States (Recruiting)
- Memorial Hermann Hospital — Houston, Texas, United States (Withdrawn)
- Ben Taub General Hospital — Houston, Texas, United States (Recruiting)
- University of Texas Health Science Center San Antonio — San Antonio, Texas, United States (Recruiting)
- University of Utah Healthcare — Salt Lake City, Utah, United States (Recruiting)
- VCU Medical Center — Richmond, Virginia, United States (Recruiting)
- Harborview Medical Center — Seattle, Washington, United States (Recruiting)
- WVU Healthcare Ruby Memorial Hospital — Morgantown, West Virginia, United States (Active_not_recruiting)
- Froedtert Hospital — Milwaukee, Wisconsin, United States (Recruiting)
- University of Calgary - Foothills Medical Centre — Calgary, Alberta, Canada (Recruiting)
- St. Michaels Hospital — Toronto, Ontario, Canada (Recruiting)
- CIUSSS-NIM Hopital du Sacre - Coeur de Montreal — Montréal, Canada (Recruiting)
Study contacts
- Principal investigator: Lori Shutter, MD — University of Pittsburgh, Pittsburgh, PA 15260
- Study coordinator: William Barsan, MD
- Email: wbarsan@umich.edu
- Phone: 734-232-2141
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.